Effect of nandrolone phenpropionate on myelopoiesis.
D000380:Agranulocytosis / Q000188:drug therapy; D045930:Anabolic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D001855:Bone Marrow Diseases / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007958:Leukocyte Count; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D009503:Neutropenia / Q000188:drug therapy; D010666:Phenylpropionates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use
D045930:Anabolic Agents; D010666:Phenylpropionates; D009277:Nandrolone